Application to Improve Patient Engagement and Decrease Postoperative Opioid Consumption in Patients for Colorectal Surgery
- Conditions
- Colorectal Surgery
- Interventions
- Behavioral: SeamlessMD® Mobile Application
- Registration Number
- NCT06350916
- Lead Sponsor
- Wake Forest University Health Sciences
- Brief Summary
The purpose of this study is to evaluate whether patient-centered educational material delivered before and immediately after surgery can help improve outcomes for patients undergoing colorectal surgery.
- Detailed Description
To analyze the impact of implementation of patient-centered educational material delivered the SeamlessMD® mobile application on perioperative Enhanced Recovery After Surgery (ERAS) metric completion rates among patients undergoing elective colorectal surgery. This is a non-interventional, prospective feasibility study. The planned study period will encompass adult patients (\>18 years) scheduled to undergo an elective colorectal surgery procedure at CMC-Main during the six-month period of December 2020 to May 2021. Patients enrolling in SeamlessMD will be prompted by the mobile app to electronically complete a validated quality-of-life assessment, the Quality of Recovery (QoR-15) evaluation, five days prior to surgery, three days postoperatively, and 30 days postoperatively.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 75
- Adult patients (>18 years old)
- Scheduled to undergo an elective colorectal surgery procedure (for benign or malignant colon or rectal pathology) at CMC-Main by one of the 5 participating colorectal surgeons (Davis, Hill, Kasten, Salo, Squires)
- Ability to provide informed consent
- Emergent, non-elective colorectal procedures
- Non-English speaking
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description SeamlessMD Mobile Application SeamlessMD® Mobile Application Participants enrolling in SeamlessMD will be prompted by the mobile app to electronically complete a validated quality-of-life assessment, the Quality of Recovery (QoR-15) evaluation over 30 days. Participants will also be prompted by the app to record their daily narcotic consumption via an "Opioid Tracker" page that requests participants enter the number of doses taken for each narcotic medication in the last 24 hours.
- Primary Outcome Measures
Name Time Method 30-day readmission 30 Days Following Hospital Discharge Readmission to any hospital facility as inpatient within 30 days of surgery
Perioperative ERAS metric completion rate 30 Days Following Hospital Discharge Completion rate for perioperative ERAS metrics
Postoperative hospital length of stay 30 Days Following Hospital Discharge Postoperative hospital length of stay
Postoperative complications 30 Days Following Hospital Discharge Occurrence of postoperative complications within 30 days, classified as Clavien-Dindo Grade I-V
- Secondary Outcome Measures
Name Time Method Postoperative Opioid Consumption 30 Days Following Hospital Discharge Postoperative opioid consumption in morphine equivalent daily doses (MEDDs) as extracted from the medical administration record (MAR) for the inpatient hospitalization period
Trial Locations
- Locations (1)
Levine Cancer Institute
🇺🇸Charlotte, North Carolina, United States